0001144204-18-019461.txt : 20180405
0001144204-18-019461.hdr.sgml : 20180405
20180405191407
ACCESSION NUMBER: 0001144204-18-019461
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180221
FILED AS OF DATE: 20180405
DATE AS OF CHANGE: 20180405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BLOCH KATHLEEN P.
CENTRAL INDEX KEY: 0001409212
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36792
FILM NUMBER: 18741655
MAIL ADDRESS:
STREET 1: 3 PERSHING COURT
CITY: NORTH BRUNSWICK
STATE: NJ
ZIP: 08902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cytosorbents Corp
CENTRAL INDEX KEY: 0001175151
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980373793
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7 DEER PARK DRIVE, SUITE K
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
BUSINESS PHONE: 973-329-8885
MAIL ADDRESS:
STREET 1: 7 DEER PARK DRIVE, SUITE K
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
FORMER COMPANY:
FORMER CONFORMED NAME: MedaSorb Technologies CORP
DATE OF NAME CHANGE: 20060807
FORMER COMPANY:
FORMER CONFORMED NAME: GILDER ENTERPRISES INC
DATE OF NAME CHANGE: 20020611
4
1
tv490542_4.xml
OWNERSHIP DOCUMENT
X0306
4
2018-02-21
0
0001175151
Cytosorbents Corp
CTSO
0001409212
BLOCH KATHLEEN P.
C/O CYTOSORBENTS CORPORATION
7 DEER PARK DRIVE, SUITE K
MONMOUTH JUNCTION
NJ
08852
0
1
0
0
Chief Financial Officer
Common Stock
2018-02-21
4
M
0
10000
2.90
A
268870
D
Common Stock
2018-02-21
4
S
0
10000
8.00
D
258870
D
Common Stock
9000
I
See Footnote
Stock Option (Right to Buy)
2.90
2018-02-21
4
M
0
10000
0
D
2015-05-29
2023-05-29
Common Stock
10000
10000
D
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2017.
Includes (i) the following RSUs that will be settled into common stock upon a "Change In Control" of CytoSorbents Corporation (the "Company"), as defined in the 2014 Long-Term Incentive Plan (the "Plan"): (a) 15,700 RSUs granted on February 24, 2017, (b) 47,000 RSUs granted on June 7, 2016, (c) 110,000 RSUs granted on April 8, 2015, and (d) 8,800 RSUs granted on March 15, 2018, (ii) the following RSUs subject to vesting as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting: (a) 10,938 of the RSUs granted to the reporting person on February 24, 2017 and unvested, (b) 7,000 of the RSUs granted on June 7, 2016 and unvested, and (c) 23,134 RSUs granted on February 28, 2018 and unvested and (iii) 30,607 shares of common stock owned by the reporting person.
Reflects securities owned by the reporting person as of the date of filing of this Form 4.
These shares are held by the reporting person's husband in a 401(k) account, and as such, the reporting person may be deemed the beneficial owner of such shares.
/s/ Kathleen P. Bloch
2018-04-05